THE PENNANT GROUP, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
THE PENNANT GROUP, INC. (PNTG) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.21 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- THE PENNANT GROUP, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 2.21M shares, a 41.75% increase year-over-year.
- THE PENNANT GROUP, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.96M shares, a 24.21% increase year-over-year.
- THE PENNANT GROUP, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 2.51M shares, a 238.81% increase year-over-year.
- THE PENNANT GROUP, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.56M shares, a 13.24% increase year-over-year.
- THE PENNANT GROUP, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.74M shares, a 37.21% increase from fiscal 2024.
- THE PENNANT GROUP, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.27M shares, a 46.21% decline from fiscal 2023.
- THE PENNANT GROUP, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 2.36M shares, a 27.04% increase from fiscal 2022.
- THE PENNANT GROUP, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.86M shares, a 289.12% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.21M shares 10-Q · filed 2026-08-05 | 2.04M shares 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | 1.96M shares 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | 1.74M shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 2.51M shares 10-Q · filed 2025-11-05 | 2.06M shares 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | 1.56M shares 10-Q · filed 2026-08-05 | 1.37M shares 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | 1.58M shares 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | 1.27M shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 742.00K shares 10-Q · filed 2025-11-05 | 1.21M shares 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | 1.38M shares 10-Q · filed 2025-08-06 | 1.79M shares 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | 2.04M shares 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | 2.36M shares 10-K · filed 2026-02-26 | |||
| 2023-09-30 | 2.72M shares 10-Q · filed 2024-11-06 | 2.28M shares 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | 2.31M shares 10-Q · filed 2024-08-06 | 2.16M shares 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | 2.00M shares 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | 1.86M shares 10-K · filed 2025-02-27 | |||
| 2022-09-30 | 1.86M shares 10-Q · filed 2023-11-07 | 1.81M shares 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | 3.83M shares 10-Q · filed 2023-08-08 | 3.81M shares 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | 1.69M shares 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | 478.00K shares 10-K · filed 2024-02-28 | |||
| 2021-09-30 | 815.00K shares 10-Q · filed 2022-11-07 | 437.00K shares 10-Q · filed 2022-11-07 | ||
| 2021-06-30 | 484.00K shares 10-Q · filed 2022-08-08 | 380.00K shares 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | 14.00K shares 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | 93.00K shares 10-K · filed 2023-02-23 | |||
| 2020-09-30 | 224.00K shares 10-Q · filed 2021-11-08 | 45.00K shares 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | 240.00K shares 10-Q · filed 2021-08-09 | 102.00K shares 10-Q · filed 2021-08-09 | ||
| 2019-12-31 | 15.00K shares 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |